CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Edge AI Is Reshaping How Clinical Trials Run
Edge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.
-
Telehealth In Clinical Trials: What Sites And Patients Think
Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
ECOA RESOURCES
-
Learn what else, in addition to good technology, study teams need for eCOA studies to succeed.
-
Find out how the shift towards a more patient-centric drug development landscape has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool to gather patient experience data in most trials today.
-
Explore how innovative processes and advanced data collection technologies like ePRO and eCOA can help contract research organizations expand their service offerings.
ECONSENT RESOURCES
-
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
IRBs are increasingly supportive of eConsent solution. Even so, researchers may find themselves in need of guidance as they prepare for an eConsent IRB review.
-
Master protocol design trials require an endless stream of consent forms, adding time, cost, and risk. Learn how a feature-rich eConsent platform can simplify those processes and improve engagement.
EPRO RESOURCES
-
Explore how innovative processes and advanced data collection technologies like ePRO and eCOA can help contract research organizations expand their service offerings.
-
Get an overview of SISCAPA's utilization of eTechnologies, specifically ePRO, and how their partnership with CDS accurately demonstrates the improvement of data collection and analysis in the biotechnology industry.
-
Discover why a unified CTMS platform is the answer for managing both the clinical trial itself and the data it produces when it comes to poorly integrated clinical trial management systems (CTMS).